Health
BioMérieux SARS-CoV-2 Serology Tests Granted FDA Emergency Use Authorization – HospiMedica
BioMérieux’s (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.
BioMérieuxs (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.The FDA has granted EUA to BioMérieuxs VIDAS SARS-COV-2 IgM and VIDAS SARS-COV-2 IgG automated qualitative assays which rapidly detect antibodies to help identify individuals with previous exposure to SARS-CoV-2. With the same protocols to differentiate IgM and IgG results, the VIDAS SARS-COV-2 IgM detects IgM specific for SARS-C…
-
Noosa News23 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General19 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News5 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business10 hours agoFord CEO makes stunning prediction about artificial intelligence